Global Hospital Infection Prevention And Overview
Hospital Infection Prevention and Control Market for was valued at USD 53.4 Billion in 2022 and is projected to grow at a CAGR of 3.5% to reach USD 75.2 Billion by 2032.
Hospital-acquired infections can be caused by the cross-infection from surface and skin of patient, equipment, and healthcare staff. Different types of products and services are available to control hospital-acquired infections such as sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. Increase in awareness regarding personal hygiene after COVID-19 is a major factor to boost the Hospital Infection Prevention and Control Market.
Global Hospital Infection Prevention And Drivers & Restraints
|
Drivers |
Restrains |
|
High Incidences of Hospital Acquired Infections |
Competitive Landscape |
|
Increasing Number of Surgical Procedures |
High-Cost |
|
Growing Geriatric Population |
End-User Noncompliance with Standards |
|
Increasing Incidences of Chronic Diseases |
|
|
Increasing Awareness of Personal Hygiene |
|
|
Technological Advancements |
|
Global Hospital Infection Prevention And Segmentations & Regional Insights
Dividing this target market into segments:
Hospital Infection Prevention and Control Market is segmented based on Product, Anti-microbial Drugs, Infections and Region.
Product Insight
On the basis of Product, the target market is segmented into Infection Prevention Supplies, Infection Prevention Equipment and Infection Prevention Services
Anti-Microbial Drugs Insight
On the basis of Anti-Microbial Drugs, the target market is segmented into Anti-bacterial Drug, Anti-Viral Drug, Anti-fungal Drug and Vaccine
Infections Insight
On the basis of Infections, the target market is segmented into Microbial Infections, Hospital Acquired Infection and Community Acquired Infection
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2022 |
|
Forecast period |
2022 – 2032 |
|
Market representation |
Revenue in USD Billion & CAGR from 2022 to 2032 |
|
Market Segmentation |
By Product - Infection Prevention Supplies, Infection Prevention Equipment and Infection Prevention Services By Anti-Microbial Drugs - Anti-bacterial Drug, Anti-Viral Drug, Anti-fungal Drug and Vaccine By Infections - Microbial Infections, Hospital Acquired Infection and Community Acquired Infection |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032.
Global Hospital Infection Prevention And Competitive Landscape & Key Players
The key players operating the Hospital Infection Prevention and Control Market includes, 3M Company, Crosstex International, Inc., Johnson & Johnson, Belimed AG, Diversey, Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Covidien plc., Ansell Ltd., Braun Melsungen AG
Global Hospital Infection Prevention And Recent News
- In March 2023, (National Association of Veterinary Technicians in America )NAVTA, Virox launch certificate program in infection prevention, to advance best practices in infection prevention. This program is a free online program designed to provide professionals with the knowledge needed to reduce the risk of spreading infection and create a safer workplace for their team, patients, and clients.
- In November 2023, The NeoIPC Consortium proudly announced the launch of a new surveillance toolkit to help neonatal intensive care units (NICUs) track and prevent hospital-acquired infections (HAIs) in high-risk newborns, including very preterm infants.
Global Hospital Infection Prevention And Highlights
FAQs
Report segments the market on the basis of product, anti-microbial drugs, infections, and region.
Budget constraints in healthcare facilities for implementing advanced infection control measures and challenges in standardizing infection prevention practices globally, leading to variations in adoption rates.
Increasing awareness of healthcare-associated infections (HAIs) and the implementation of stringent regulatory guidelines for infection prevention.
By region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.
3M Company,Crosstex International, Inc.,Johnson & Johnson,Belimed AG,Diversey, Inc.,Becton, Dickinson and Company,Cardinal Health, Inc.,Covidien plc.,Ansell Ltd.,Braun Melsungen AG